116 related articles for article (PubMed ID: 3053000)
41. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Yu L; Jia C; Wang X; Lu P; Tian M; Wang W; Lou G
Am J Med Sci; 2011 Feb; 341(2):96-100. PubMed ID: 21030858
[TBL] [Abstract][Full Text] [Related]
43. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
44. [Computed tomography and the clinical picture of carcinoma of the uterine cervix].
Köster O; Braun P; Lackner K; Leyendecker G
Rofo; 1984 Feb; 140(2):136-44. PubMed ID: 6420277
[TBL] [Abstract][Full Text] [Related]
45. Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
Hempel JM; Kloeckner R; Krick S; Pinto Dos Santos D; Schadmand-Fischer S; Boeßert P; Bisdas S; Weber MM; Fottner C; Musholt TJ; Schreckenberger M; Miederer M
Cancer Imaging; 2016 Nov; 16(1):37. PubMed ID: 27809936
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
47. Revisiting the role of computerized tomographic scan and cystoscopy for detecting bladder invasion in the revised FIGO staging system for carcinoma of the uterine cervix.
Sharma DN; Thulkar S; Goyal S; Shukla NK; Kumar S; Rath GK; Julka PK; Saini G; Bahl A
Int J Gynecol Cancer; 2010 Apr; 20(3):368-72. PubMed ID: 20375799
[TBL] [Abstract][Full Text] [Related]
48. [Value of CT scanning in the diagnosis of early cervical carcinoma].
Dai JR; Zhang X; Jiang LX; Li J; Zhang J
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):151-4. PubMed ID: 16750026
[TBL] [Abstract][Full Text] [Related]
49. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
[TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of diagnostic methods and characteristics of patients operated on for cervical cancer in Lithuania, 1998-2000].
el-Aawar B
Medicina (Kaunas); 2002; 38(6):597-610. PubMed ID: 12474666
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY
Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087
[TBL] [Abstract][Full Text] [Related]
53. Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT: Systematic Review and Meta-analysis.
Cheung PK; Chin RY; Eslick GD
Otolaryngol Head Neck Surg; 2016 Mar; 154(3):421-32. PubMed ID: 26715675
[TBL] [Abstract][Full Text] [Related]
54. Pretreatment lymphangiography in carcinoma of the uterine cervix.
Leman MH; Park RC; Barham ED; Chism SE; Petty WM; Patow WE
Gynecol Oncol; 1975 Dec; 3(4):354-60. PubMed ID: 1213599
[No Abstract] [Full Text] [Related]
55. Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma.
Wang F; Shen LY; Ma SH; Li N; Yang Z; Chen KN
Dis Esophagus; 2013; 26(8):832-7. PubMed ID: 22947128
[TBL] [Abstract][Full Text] [Related]
56. [MRT diagnosis of recurrence of gynecologic tumors].
Lorenzen M; Nicolas V; Kopp A
Rofo; 1994 Dec; 161(6):526-30. PubMed ID: 7803776
[TBL] [Abstract][Full Text] [Related]
57. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma.
Burke TW; Hoskins WJ; Heller PB; Shen MC; Weiser EB; Park RC
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):382-5. PubMed ID: 3822285
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
59. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
Maharjan S; Sharma P; Patel CD; Sharma DN; Dhull VS; Jain SK; Thulkar S; Malhotra A; Kumar R
Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography.
Park DH; Kim KH; Park SY; Lee BH; Choi CW; Chin SY
Korean J Radiol; 2000; 1(1):51-5. PubMed ID: 11752929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
